New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report | Zendy

Mohaghegh Fatemeh | Zendy; Hatami Parvaneh | Zendy; Refaghat Arezoo | Zendy; Mehdizadeh Mohammadjavad | Zendy; Aryanian Zeinab | Zendy; Mohandesi Nessa Aghazadeh | Zendy; Afshar Zeinab Mohseni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report

Author(s) -

Mohaghegh Fatemeh,

Hatami Parvaneh,

Refaghat Arezoo,

Mehdizadeh Mohammadjavad,

Aryanian Zeinab,

Mohandesi Nessa Aghazadeh,

Afshar Zeinab Mohseni

Publication year - 2022

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.5910

Subject(s) - pemphigus foliaceus , medicine , covid-19 , virology , dermatology , pemphigus , multiple sclerosis , immunology , pathology , infectious disease (medical specialty) , disease , autoantibody , antibody , outbreak

Development of pemphigus foliaceus (PF) following SARS‐CoV‐2 infection has only been reported in one patient who had received Bamlanivimab and thus might be considered as a drug‐induced case of PF. Here, we reported the first case of PF arising solely after COVID infection without taking any culprit drug.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research